- PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

Description:

Can researchers continue to collect data from mentally incapacitated participants? ... PARTICIPANT BECOMES MENTALLY INCAPACITATED. Incapable of providing ... – PowerPoint PPT presentation

Number of Views:89
Avg rating:3.0/5.0
Slides: 28
Provided by: caro266
Category:

less

Transcript and Presenter's Notes

Title:


1
Étude De Faisabilité Pour L'étude Longitudinale
Canadienne Sur Le Vieillissement (ELCV)
Exploration Des Attitudes Sur L Incapacité
Mentale Et Participation À Long Terme
-----------------------------------
  • Feasibility Study for the Canadian Longitudinal
    Study on Aging (CLSA)  
  • Exploring Attitudes about Mental Incapacity and
    Long Term Participation
  • Dr. Linda Furlini
  •  

2
OUTLINE
  • Overview of the CLSA
  • Introduction to Feasibility Study
  • Emerging questions
  • Background
  • Main Objectives
  • Proposed Methodology
  • Anticipated Results

3
Overview of the CLSA
  • Examine aging as a dynamic process
  • Successful aging
  • Broad , multidisciplinary long term
    observational
  • study
  • Study involves no experimentation
  • Variety of data collection methods
  • Information collected on the changing
    biological, medical, psychological, social,
    and economic aspects of
    older Canadians.

4
Overview of the CLSA
  • REQUIRES THE LONG TERM PARTICIPATION OF
    PARTICIPANTS
  • 50,000 Canadian women and men aged 40 to 84
    living in the community
  • followed for a period of at least 20 years
  • not cognitively impaired at baseline
  • Repeated assessments
  • Every 3 years, until age 80
  • Yearly thereafter
  • Linkage to databases

5
Overview of the CLSA
  • 50,000 individuals will be interviewed with
    questionnaires administered over the phone or in
    person
  • Subgroup of 30,000 individuals selected to
    undergo in-depth assessment over the course of
    the study
  • Remaining 20,000 participating primarily through
    telephone interviews

6
Data Collection Sites
  • NFLD
  • Nova Scotia
  • Québec
  • Ontario
  • Manitoba
  • Alberta
  • BC
  • St. Johns
  • Halifax
  • Sherbrooke Montréal
  • Ottawa Ham/GTA
  • Winnipeg
  • Calgary
  • Vancouver Victoria

7
Introduction
  • CLSA researchers will face particular
    challenges
  • Participants must provide ongoing informed
    consent for a period of not less than twenty
    years.
  • Emerging questions
  • Relevant and important to most long-term
    observational studies involving older adults

8
Emerging questions
  • If mental incapacity develops
  • Can researchers use data for purposes that were
    unforeseen at the time participants provided
    Informed Consent (IC)?
  • Can researchers continue to collect data from
    mentally incapacitated participants?
  • Will they be permitted to continue using data
    that have already been collected?

9
Objective
  • THE MAIN OBJECTIVE OF THIS FEASIBLITY STUDY IS
    TO DETERMINE HOW POTENTIAL CLSA PARTICIPANTS
    PERCEIVE ONGOING INFORMED CONSENT IF MENTAL
    INCAPACITY DEVELOPS

10
Background
  • Mental Capacity to provide Informed Consent
  • Aging significantly increases likelihood of
    suffering from diseases that affect mental
    capacity to provide informed consent,
    particularly dementia
  • Current incidence considerably underestimated
    (Canadian Study on Health and Aging Working
    Group, 2000)
  • Prevalence will be magnified by aging baby
    boomers
  • Older persons may be affected by a variety of
    other conditions and diseases, such as mental
    illness
  • Some conditions may be transient, such as
    recovering from a stroke

11
Risks of Participation
  • Participants will receive little or no personal
    benefit
  • A tendency to focus on risks in studies, such as
    the CLSA, where participants receive little or no
    personal benefit
  • Potential risk Threat to personal privacy
  • (Data collection, data linkage, data storage,
    future uses of DNA samples)
  • Researchers face unique challenges in monitoring
    potential risks and conveying such information to
    participants

12
Risks of Participation
  • Future advances in research may introduce risks
    that are unforeseeable at the inception of a
    study
  • Unforeseeable risks take on greater importance
    when participants become mentally incapacitated
  • Unable to contribute to decisions about personal
    privacy that may have far-reaching effects
  • An appreciation of public attitudes about the
    risks of participation in LOR is needed

13
Substitute Decision-Making
  • Substitute Decision-Makers (proxies who will
    answer for the participant in the event of mental
    incapacity)
  • Legislation varies from province to province
  • In Québec, substitute decision-makers are
    required for experimental research and their
    legal status remains ambiguous for research
    involving minimal risk
  • Current laws do not specifically address LOR
    involving minimal risk
  • Little is known about the willingness of
    participants to appoint SDMs or what their
    appointment may entail.

14
Substitute Decision-Making
  • Usually family caregivers
  • Possess health data that would be inaccessible
    were they not involved
  • May contribute to the reliability of participant
    information
  • Facilitates patient tracing
  • Involving Substitute decision-makers reduces
    attrition

15
Substitute Decision-Making
  • Researchers must be attuned to their specific
    needs and how to meet them
  • Attrition is reduced when caregiver-centered
    approaches are used
  • Further exploration is required about caregivers
    specific needs as SDMs

16
Caregivers and SDM
  • Past research
  • Diagnosis
  • Gray Zone
  • Ethical tensions

17
Substitute Decision-Making
  • Lack information about
  • information gathered about them and developments
    of new technology
  • substitute decision-making
  • Resources
  • Educational needs

18
Substitute Decision-Making
  • Means to appoint Substitute Decision-Makers
  • Advance Directives (e.g. Mandat en cas
    dinaptitude, Procuration)
  • Legal document allowing participant to appoint a
    substitute decision-maker for health purposes,
    including research
  • Research Advance Directives (specifically for
    CLSA)
  • Informed Consent Form allowing participant to
    appoint a substitute decision-maker at inception
    of the study for purposes of the research only
  • Research Study Advocates
  • Consent Form allowing participant to appoint
    professionals with some expertise in substitute
    decision-making

19
CANADIAN LONGITUDINAL STUDY ON AGING (CLSA)
INFORMED CONSENT PROCESS
CLSA PARTICIPANT
PARTICIPANT BECOMES MENTALLY INCAPACITATED
  • OVER TIME MENTAL INCAPACITY DEVELOPS
  • possible age-related diseases affecting mental
    capacity to provide informed consent

EVALUATE RISK OF PARTICIPATION
MINIMAL RISKS
(non invasive)
PRIVACY CONFIDENTIALITY (DNA, data linkage,
etc.)
Incapable of providing informed consent
  • ALZHEIMERS
  • VASCULAR DEMENTIA
  • MENTAL ILLNESS

OPTIONS
SUBSTITUE DECISION MAKER MECHANISM OF INFORMED
CONSENT
WITHDRAWS
REMAINS IN STUDY
RESEARCH ADVANCED DIRECTIVES
RESEARCH STUDY ADVOCATES
ADVANCED DIRECTIVES
NO FOLLOW-UP INFORMATION AVAILABLE
20
Public Engagement
  • Public Engagement
  • The perspectives of potential participants and
    substitute decision-makers are needed
  • to help identify problems
  • to reduce confusion about the CLSA
  • to ensure public trust

21
Need for Feasibility Study
  • Little is known about how Canadians view
    providing informed consent if mental incapacity
    develops during the course of a longitudinal
    observational study

22
Main Objective Of Feasibility Study
  • EXPLORE HOW POTENTIAL CLSA PARTICIPANTS PERCIEVE
    ONGOING INFORMED CONSENT IF MENTAL INCAPACITY
    DEVELOPS.

23
  • Questions under study include
  • Would Canadians enrolled in the study be willing
    to participate if they became mentally
    incapacitated during the course of the study?
  • Who will make decisions about this study on their
    behalf?
  • If substitute decision-makers are used, how will
    they be appointed? What will be their roles and
    responsibilities?
  • What are the risks of participation (e.g., due to
    developments in technology, data and/or stored
    biological samples that may be used for purposes
    that were unforeseen when the study began).
  • What types of information do participants or
    their substitute decision-makers need to
    encourage ongoing participation?

24
Proposed Methodology
  • QUALITATIVE
  • Focus groups and interviews
  • Participant recruitment
  • Potential Participants
  • Potential Substitute decision-makers

25
  • Proposed Methodology
  • Complementary Analytic Strategies
  • (Maxwell Miller, 1996)
  • Categorization (Constant Comparison)
  • Contextualization

26
  • Categorization
  • Common elements of experience and group them into
    conceptual themes
  • Contextualization
  • Uniqueness of experience and specific context

27
  • Anticipated results will help
  • Appreciate attitudes regarding ethical issues
    involving mental incapacity, consent, substitute
    decision-making, risks of participation, threats
    to personal privacy, and the content and quality
    of relevant information provided to the study's
    participants
  • Identify and address challenges to retaining
    participants in the CLSA, thus ensuring its
    success
Write a Comment
User Comments (0)
About PowerShow.com